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ABSTRACT Purpose: To determine the merits 
of a robot at the community pharmacy in a quasi-
experiment. Method: The applied methods for 
data-collection were barcode-time measurements, 
direct observations, time-interval studies, and 
tally at a Dutch community pharmacy. The topics 
consisted of workload, waiting times, congestion, 
slack, general work, counter work, and work at 
the consultation room. The topics were studied in 
pre-test and post-test stages, each stage during six 
weeks. By using these topics and some additional 
data from the pharmacy, the economics of the 
robot were also assessed. Results: The workload 
decreased with 15 prescriptions per person per 
day. The waiting times decreased with one minute 
and 18 seconds per dispensing process, reducing 
the wait until counter contact. The day congestion 
decreased with one hour 27 minutes and 36 
seconds, and the day slack increased with 28 
minutes. The analysis of the general work showed 
no appreciable difference in the bulk of the care-
related activities and the other activities. 
However, some work was re-shuffled: 7% 
increase at counter work and 7% decrease at 
logistics. Moreover, statistically significant 
increases were observed at counter work (5%) and 
robot work (4%), and significant decreases at 
telephone (3%) and filling work in presence of the 
patient (4%). The counter tally study showed a 
rise in care-related activities with 8%. Moreover, 
it also illuminated a statistically significant 
decrease at no information (11%) and an increase 
at only social (2%). The consultation room was 
never used during the study. The pharmacy 
economics of the robot showed that the robot had 
high estimated costs for purchase, depreciation, 
and maintenance: EUR 187,024 in the first year. 
Moreover, the robot had positive impact on 
waiting times, congestion, staffing, logistics, and 
care-related work, which was estimated on EUR 
91,198 in the first year. The estimated payback 
time of the robot was three years. Conclusions: 
An introduction of the robot may indeed have the 
often supposed positive effects on pharmaceutical 
care. Even though the costs are high and the 
technical problems are present, the robot seems to 
be financial beneficial after three years. The robot 
can create space for pharmaceutical care, but it 




Currently, there seems to be an increasing number 
of community pharmacies which introduce a 
robot in order to reduce the time spent on logistic 
tasks and improve the provision of care in The 
Netherlands.1 Although much of the available 
literature deals with the merits and drawbacks of 
the robot introduction at the pharmacy, it is yet 
unknown to what extent this machine increases 
the care work that is done when compared with a 
human working system. In order to address this 
question the waiting times, congestion and slack, 
and work content were studied at a community-
based pharmacy in The Netherlands. This study 
describes if the introduction of the robot at this 
pharmacy stimulated care-related activities and to 
what extent it is economically feasible. The 
objective of this study was therefore to determine 
the influence of the robot on the care-related work 
at the community pharmacy and to estimate the 
economic value. 
Robotization of the logistic parts of the 
dispensing process is relatively new, but from 
pharmaceutical and organizational perspectives 
promising. The organization principle of 
robotization is simple: logistic tasks are 
transferred to a robot (filling) and to personnel 
with a low education (refilling stock) [1]. The 
efficiency advantages are supposed to be twofold: 
the machine works faster than humans and the 
refill is much simpler and can therefore be staffed 
cheaper. This shift of work increases the available 
time for pharmaceutical care at the educated staff, 
for instance, for a conversation at the counter or 
for continuing education. In this study it was 
investigated to what extent the work shifted 
towards pharmaceutical care. This principle is 
vulnerable as the advantages of improved 
efficiency may be used for other purposes, not in 
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The earliest experiences in The Netherlands show 
that the advantages of robotization are indeed 
used for the strengthening of the implementation 
of pharmaceutical care [1]. However, technical 
failure remains a serious risk. The time to repair a 
robot after mechanical failures is a serious 
concern. Even though the robot may be opened 
and used as a regular stockroom, the exact 
location of the stock is mostly hard to find in the 
machine. With the regular pharmacy computer it 
can be done, but it remains far from ideal. For 
some pharmacists this has indeed been a valid 
argument to stop working with the robot [2] or 
may be the reason that a nation-wide technology 
take-up has failed to appear. In the scarcely 
available literature the merits and drawbacks of 
the robot introduction at the pharmacy are 
discussed, but their main contribution is to seek 
the efficiency advantages [3-6]. None of the 
research has studied the indirect effects: the 
improvement in terms of care-related activities. 
That is surprising because improvement of the 
care activities is a main argument to introduce a 
robot into the pharmacy. Consequently, this 
current study seeks to fill that gap.  
First, it reports the basic costs : purchase, 
depreciation, and maintenance. Next, it seeks 
costs and benefits in combining studies of 
workload, waiting times, congestion, and slack 
with the work contents in general, at the counter, 
and in the separate consultation room. Finally, the 
study estimates the pharmacy economics of the 
robot. All under the condition that the pharmacist 
had the intention to improve pharmaceutical care 
at the pharmacy. 
At the studied pharmacy the robot could store and 
manage slow, medium and fast moving items and 
manage stock independently. For the stock refill 
the robot scans and recognizes packs without 
manual intervention. Packs can be either 
randomly placed onto the shelves of the loading 
door in a relatively slow motion or identical items 
are placed on one shelf and only the first pack 
will be placed onto the scan station in a faster 
mode. On receipt of a stock request, the robot will 
pick a pack from its stores and deliver it via a 
transport system to the outlet near the counter 
from where the request has been made. For more 
than one pack of the same medication, the robot 
does not combine the delivery in a batch, but 
picks one pack at a time. When packs are loaded 
into the door, a security blind isolates the robot’s 
central working area so that the robot can 
continue to work whilst packs are being placed 
into the storage door. 
METHODS 
 
A Dutch community pharmacy was selected 
based on their motivation to participate in the 
study, their intention to use the robot introduction 
for the improvement of pharmaceutical care, and 
because it was a best case practice. The pharmacy 
was in the top ten of a secret shopper study 
performed at well-over 500 community 
pharmacies by the Dutch pharmacy consultancy 
firm AMP [7]. The study was not designed for 
generalization purposes: the sample was far too 
small. It may therefore be regarded as a study in 
the context of discovery; the study was designed 
to reveal the impact of the robot on the 
performance of pharmaceutical care. The main 
study distinguishes care-related from other work. 
Care-related work was defined as the work where 
at least parts of the content would relate to 
pharmacotherapeutic consultation; with other 
work this link could not be established 
reasonably. In the study eight main topics were 
investigated: basic costs of the robot, workload, 
waiting times, congestion and slack, general 
work, counter work, consultation-room work, and 
overall economics of the robot.  
The first topic was basic costs comprising 
initial purchase, depreciation, and maintenance 
and was expressed in euro (EUR). The next topic, 
workload was described for both periods as a 
precondition to perform the study: to what extent 
were the periods really comparable. Moreover, 
the main data-collection various techniques were 
used for five additional topics: waiting times, 
congestion and slack, general work, counter work, 
and consultation-room work. Finally, the last 
topic pharmacy economics of the robot were 
estimated with the above and additional data from 
the pharmacy. This allowed estimations of costs 
and merits of the robot during the first year and an 
estimation of the payback time. All data were 
collected during six weeks in the spring of 2004 
(pre-test stage without robot) and six weeks in the 
autumn of 2005 (post-test stage robot). Each topic 
was studied during two weeks per stage.  
Firstly, the basic costs comprised initial 
purchase, depreciation, and maintenance. The 
data were reported by the pharmacy and the costs 
were calculated in euro. The total write-down 
term was ten years in which the cost will be 
equally distributed in yearly chunks. The 
pharmacy had a maintenance contract, which 
included the costs for reparations in case of 
mechanical troubles. The costs of this contract 
were reported. 






Secondly, the workload was defined as 
the mean number of prescriptions handled per 
person per day. It was used as a rough indication 
of how busy it was during both periods. The 
calculation was based upon the total number of 
prescriptions and the total fulltime pharmacist 
equivalence (FTE) for the team. The FTE gives 
expression to the number of full time and part 
time pharmacy staff occupied at the pharmacy 
during the study, including pharmacists and 
pharmacy assistants. The pharmacists counted the 
number of prescriptions and FTE each day during 
six weeks.  
Thirdly, the waiting times were defined as 
the time patients had to wait in the waiting area 
and at the counter. These data were collected with 
barcode-time measurements. The measurements 
were patient oriented: the times the patient had to 
wait in the waiting area and at the counter. With 
direct observations all patients were linked to a 
unique barcode number on a list which, when 
registered, was linked to the time. This produced 
two time periods: a waiting time until the first 
counter contact and a waiting time after the first 
counter contact. 
Fourthly, congestion was when four or 
more patients were present in the waiting area and 
slack was when no patients were present. For both 
issues direct observations were made in the 
waiting area. Each time when four or more 
patients waited or when no patient was waiting, 
the period from start until end was registered. 
Waiting times, congestion, and slack were studied 
in the first two weeks of each measurement period 
and were expressed in hours, minutes, and 
seconds (hh:mm:ss).  
Fifthly, general work was defined as all 
the work at the pharmacy. For these work 
measurements pocket-size machines were used. 
The machines made a sound signal, roughly four 
times an hour in a randomly produced time 
interval. Each time when the machine made a 
sound signal, the staff member registered in 
eleven categories what she or he did. These 
eleven categories comprised care-related work 
and general work. The care-related work was: 
counter care, counter other, conversation room, 
telephone, computer work, ex tempore 
preparations, and home delivery work. The 
definitions in this category were: counter care: 
advice on medication, medical aids or disease; 
counter other: helping patients at the counter, not 
being couter care; conversation room: all 
conversations in this room; telephone: all 
telephone conversations; computer work: 
prescription-related computer work, not at the 
counter; ex tempore preparations: preparing or 
making medicine at the pharmacy; and home care 
work: all tasks in relation with the home care. The 
general work was filling work in and out patient 
presence, logistical work, office work, robot 
problems, and other. The definitions in this 
category were: filling work in patient presence: 
collecting the medication in presence of the 
patient; filling work out of patient presence: 
collecting the medication without the presence of 
the patient; logistical work: ordering and handling 
medical goods; office work: stock mutations, 
claims, expiry dates control, and quality system; 
robot work: work to fix technical problems or 
malfunctioning of the robot; other: all other 
activities at the community pharmacy. This 
measurement was made in the middle two weeks 
of each measurement period.  
Sixthly, counter work was defined as all 
work at the counter. For these work 
measurements registration lists were used to allow 
tally. After each counter contact with the patient, 
the staff member qualified the nature of the 
conversation, also in eleven categories. These 
eleven categories also comprised care-related 
work and general work. The care-related work 
was: brief medication browse, first-time 
dispensing, second-time dispensing, instruction, 
medication surveillance, medication counseling, 
self care, and information about disease or life 
style. The definitions in this category were: brief 
medication browse: a quick scan of the 
medication together with the patient, first-time 
dispensing: conversation about a first dispense of 
a certain drug; second-time dispensing: follow-up 
conversation about the second dispense of a 
certain drug; instruction: instruction on patient 
skills to take medication or to use medical aids, 
e.g. diabetes injection or COPD inhaler; 
medication surveillance: conversation about the 
comparison of new medicine with medication 
history; medication counseling: conversation 
about medication use or optimization of it; self 
care: OTC counseling and other conversations 
about the use of nonprescription medication; and 
information about disease or lifestyle: 
conversation about patients’ disease or lifestyle. 
The general work was: only social, other, and no 
information. The definitions in this category 
were: only social: conversation about patients’ 
personal situation; other: all other counter 
conversations; no information: only dispensing 
medicine. This measurement was made in the last 
two weeks of each measurement period. 






Seventhly, consultation-room work was 
defined as all work in the separate consultation 
room. For these work measurements registration 
lists were also used to allow tally. After each 
consultation, the staff member qualified the nature 
of the conversation in six categories. These six 
categories also comprised care-related work and 
general work. The care-related work was: first 
time use, instruction, medication counseling, and 
information about disease. The definitions in this 
category were: first time use: conversation about a 
first use; instruction: instruction on patient skills 
to take medication or to use medical aids, e.g. 
diabetes injection, COPD inhaler or incontinence 
products; medication counseling: conversation 
about medication use or optimization of it; and 
information about disease: conversation about 
patients’ disease. The general work was: only 
social and other. The definitions in this last 
category were: only social: conversation about 
patients’ personal situation; and other: all other 
conversations in the consultation room. This 
measurement was also made at the pharmacy in 
the last two weeks of each measurement period. 
The results between the situations without a robot 
and with a robot were compared.  
Finally, the overall economics were 
defined as the costs and merits that were caused 
by the robot introduction. In these analyses the 
basic and additional costs and benefits were 
combined and compared in order to allow an 
estimation of the merits in the first year. These 
financial estimations of changes comprised extra 
work to overcome robot flaws, filling and 
logistical work, counter work, workload, waiting 
times, congestion and slack, and pharmaceutical 
care. First, the extra work that had to be done by 
the pharmacy staff in order to overcome technical 
failure of the robot was derived from the general 
work study. These results were combined with the 
data on the available FTE from the workload 
study and the average year salary reported by the 
pharmacy and resulted in an estimation of the 
personnel costs to solve the technical problems. 
Second, a similar approach was used for an 
estimation of the costs of changes in logistics and 
counter work. Next, an estimation of the costs of 
changes in workload was made with the data on 
the workload study and the average year salary. 
Fourth, an estimation of the costs of changes in 
the waiting time was based upon the results of the 
waiting time study, in combination with reports 
from the pharmacy about the mean number of 
patients per week, the number of weeks per year, 
the working hours per year per person, and the 
average year salary. Fifth, an estimation of the 
costs of changes in congestion and slack were 
based upon the results of the congestion study, in 
combination with the number of weeks and 
working hours per year per person and the 
average year salary, as reported by the pharmacy. 
Sixth, an estimation of the costs of changes in 
pharmaceutical care was calculated with the 
counter work study. By combining these results 
with the mean capacity utilization for counter 
work in the new situation and the average year 
salary as reported by the pharmacy, the merits 
were calculated. Consequently, with the results 
from above methods the total estimated costs and 
merits could be calculated for the first year. 
Finally, and based upon the results of methods 




The comparison between the two situations for 
the topics work load, waiting times, congestion, 
and slack were population measurements. 
Therefore, a statistical test if the reported 
difference was the result of chance alone (if there 
is really no difference in the population from 
which you drew your sample) is not relevant [8]. 
Be reminded that the sample for the above topics 
equals the population in the period described. 
Consequently the analyses of these topics were 
restricted to descriptive statistics. In contrast, the 
comparison between the two situations for the 
topics general work, counter work, and work at 
the consultation room were samples. 
Consequently, both descriptive statistics and the 
Mann-Whitney U test were used to determine 
significant differences. Given the relatively small 
sample size in the data matrix (day frequencies 
per cell) and the fact that all observations have 
higher than ordinal scales the Mann-Whitney U 
test is a good choice [9-11]. The Mann Whitney U 
test is the most widely-used non-parametric test 
for determining the significance of the difference 
between two groups. In each analysis the pre-test 
and post-test groups were compared as being 
independent samples. The test hypothesis was H0: 
when there is no difference between pre test and 
post test (or more exactly formulated: it tests 
whether the major part of the population A (on 
the basis of pre-test sample a) equals the main 
part of population B (on the basis of post-test 
sample b), in this case with an α=.05). If the 
calculated p-value ≤.05 H0 will be rejected and it 
will be assumed that the differences between the 
pre test and post are significant. The comparison 






was made with the rough data: the observed 




Table 1 describes the basic costs of the robot. 
Tables 2-6 compare the situation of the pharmacy 
without and with a robot for the topics workload, 
waiting times, congestion and slack, general 
work, and counter work. There is no table for the 
consultation-room work since no consultations 
were made during this study: the room was never 
used. Tables 7-8 deal with the cost and merits of 
the robot and the payback time. Be reminded that 
the data in table 1 were based upon initial 
pharmacy reports, table 2 were based upon 
measurements during six weeks, tables 3-6 upon 
two weeks per stage, and tables 7-8 upon a 
combination of all of the above.  
 
Table 1. Basic costs of the robot  
Items Costs 
 
Purchase (initial cost) EUR 150,000 
Maintenance cost (yearly cost) EUR 9,000 
Depreciation  (yearly cost)  EUR 15,000 
 
 
Table 1 deals with the costs for the initial 
purchase, depreciation, and the costs for 
maintenance in euro. The initial purchase was 
EUR 150,000 and with a total write-down term of 
ten years in which the cost will be equally 
distributed in chunks of EUR 15,000 yearly. For 
maintenance cost the pharmacy had a contract, 
which included the costs for reparations in case of 
mechanical troubles. The contract costs EUR 
9,000 per year. 
Table 2 deals with the workload and 
shows that the number of prescriptions dispensed 
was 546 less in the post-test stage, but still 
comparable. It presents the sum, mean and 
standard deviation for the number of prescriptions 
and team fulltime equivalence (FTE). Moreover, 
it presents the mean and standard deviation for the 
prescriptions per person per day. The table shows 
that the FTE was much higher in the post-test 
stage, a mean of 1.7 staff members extra per day. 
As a consequence the workload, expressed in the 
mean number prescriptions handled per person 
per day, was much lower at the post-test stage 
than at the pre-test stage; respectively 53 and 68 
prescriptions. A decrease in the workload of 15 
prescriptions per person per day. 
Table 2 Workload  
 
 
Table 3 deals with the waiting times and presents 
the mean waiting time and standard deviation. 
The table shows that the total waiting time 
decreased with one minute and 18 seconds per 
dispensing process. Patients had well-over a 
minute shorter waiting time until counter contact. 
The waiting time after counter contact remained 
relatively stable. All standard deviations were 
lower in the situation with the robot. Less waiting 
times differed from the mean, indicating that the 
different waits were more comparable in duration. 
 
 






Sum total Mean Standard 
deviation 
Number of 




213 7.1 1.3 
Prescriptions per 






Sum total Mean Standard 
deviation 
Number of 




263 8.8 1.5 
Prescriptions per 
person per day  53 15.2 







Waiting time until counter contact 00:05:11 00:05:14 
Waiting time after counter contact 00:02:59 00:00:57 
Total waiting time 00:08:10 00:03:38 






Waiting time until counter contact 00:03:48 00:04:10 
Waiting time after counter contact 00:03:04 00:00:31 
Total waiting time 00:06:52 00:03:28 






Table 4 comprises the observed congestion and 
slack. It presents the cumulative observed time 
periods and frequencies of congestion and slack, 
the mean and frequencies per day, and the 
standard deviation. The table shows that the sum 
total congestion decreased with more than 15 
hours per two weeks and the frequency dropped 
with almost 50%, from 238 to 121 observed 
congestion time intervals. As a consequence, the 
mean congestion decreased with one hour 27 
minutes and 36 seconds per day and the observed 
daily frequencies were halved. The table also 
shows that the sum total slack increased with 
more than 4 hours per two weeks and the 
frequency rose with almost 20%, from 175 to 210 
observed slack time intervals. Therefore, slack 
increased with 28 minutes per day and the 
observed frequencies were comparable: three 
more per day. The standard deviations were also 
comparable: it decreased slightly at congestion 
and increased slightly at slack. 
Table 5 deals with the general work at the 
pharmacy. It presents the cumulative observed 
frequencies per item, the mean per day, the 
percentage per item as part of all observed 
frequencies, the standard deviation, and statistical 
significant differences. The table shows that there 
was no appreciable difference in the proportion 
between the care-related activities and other 
activities with the introduction of the robot. The 
study comprised 2665 registrations in the pre-test 
and 3143 registrations in the post-test spread in 
two weeks each. The proportion of care-related 
activities was 1039 registrations (39%) in the pre-
test and 1179 registrations in the post-test (38%). 
The proportion of other activities was 1626 
registrations (61%) in the pre-test and 1964 
registrations in the post-test (62%). Consequently, 
it is argued that the general work in the situation 
with the robot was for 38% care-related (39% 
without robot) and for 62% not-care-related (61% 
without robot).  
However, on the detailed level the results 
show some interesting statistically significant 
differences. First, the results show a significant 
increase of 5% in the observed activities at 
counter other (without robot: 7%; with: 12%) and 
of 4% at robot work (without robot: 0%; with: 
4%); both having a calculated p-value of less than 
.01. Second, the results show a significant 
decrease of 3% at telephone work (without: 6%; 
with: 3%) and of 4% at filling work in patient 
presence (without robot: 8%; with: 4%); both also 
having a calculated p-value of less than .01. 
Third, it is interesting to mention that other 
changes are remarkable, even though they are not 
statistically significant. The counter work, 
including the categories counter care and counter 
other, has increased with 7% (without robot: 12%; 
with: 19%). Moreover, the filling work, including 
the categories filling work in patient’s presence 
and filling work out of patient’s presence, has 
decreased with 8% (without robot: 22%; with: 
16%). 
Table 6 deals with the counter work at the 
pharmacy. It presents the cumulative observed 
frequencies per item, the mean per day, the 
percentage per item as part of all observed 
frequencies, the standard deviation, and statistical 
significant differences. The table shows that the 
care-related activities have risen (without robot: 
71%; with: 79%). The study comprised 1197 
counter registrations in the pre-test and 1052 
counter registrations in the post-test spread in two 
weeks each. The proportion of care-related 
activities was 855 registrations (71%) in the pre-
test and 827 registrations in the post-test (79%). 
The proportion of other activities was 342 
registrations (29%) in the pre-test and 225 
registrations in the post-test (21%). Consequently, 
it is argued that the counter work in the situation 
with the robot was for 79% care-related (71% 
without) and for 21% not-care-related (29% 
without).  
However, again on the detailed level the 
results show some interesting differences which 
were statistically significant. First, the results 
show a very relevant and statistically significant 
decrease in the observed activities at no 
information (without robot: 26%; with: 15%). 
Second, the results show a significant increase at 
only social (without: 0%; with: 2%). Both 
differences were having a calculated p-value of 
less than .01. Third, it is also interesting to 
mention that another important changes was 
registered, even though it was not statistically 
significant. The brief medication browse has 
increased with 6% (without: 51%; with: 57%).  
Table 7 shows the estimated costs and 
merits of the robot in the first year. The costs of 
the robot comprised initial purchase, depreciation, 
maintenance, and extra work to overcome 
technical failure of robot. Earlier, we have learned 
from table 1 that the yearly costs associated with 
the initial purchase were EUR 150,000, with 
depreciation EUR 15,000, and with maintenance 
EUR 9,000. Moreover, the extra work that had to 
be done by the pharmacy staff in order to 
overcome technical failure of the robot comprised 
an increase of 4% of the total FTE in the new






Table 4 Congestion and slack  
Pharmacy situation Without robot 
 







Frequency Mean  Frequency Standard 
deviation 
Sum total Frequency Mean  Frequency Standard 
deviation 
Congestion  
(four or more patients waiting) 34:15:04 238 03:25:30 24 00:15:50 19:39:00 121 01:57:54 12 00:11:22 
Slack  
(no patients waiting) 09:15:55 175 00:55:36 18 00:03:21 13:56:00 210 01:23:36 21 00:04:10 
 
Table 5 General work  







Sum total Mean Percentage of 










Counter care 141 14.1 5% 10.9 224 22.4 7% 7.2  
Counter other 197 19.7 7% 8.1 383 38.3 12% 12.5 ** 
Conversation room 1 0.1 0% 0.3 3 0.3 0% 1.0  
Telephone 166 16.6 6% 6.1 99 9.9 3% 5.0 ** 
Computer work 289 28.9 11% 10.6 231 23.1 7% 5.1  
Ex tempore preparations 41 4.1 2% 4.1 42 4.2 1% 3.5  
Home delivery work 204 20.4 8% 7.9 197 19.7 6% 14.9  
Subtotal care-related activities 1039 103.9 39% 10.4 1179 117.9 38% 25.0  
Filling work in patient presence 215 21.5 8% 8.4 111 11.1 4% 7.5 ** 
Filling work out of patient presence 375 37.5 14% 18.9 375 37.5 12% 20.9  
Logistical work 168 16.8 6% 5.9 149 14.9 5% 8.9  
Office work 55 5.5 2% 3.2 168 16.8 5% 18.7  
Robot work 0 0.0 0% 0.0 120 12.0 4% 12.3 ** 
Other 813 81.3 31% 22.4 1041 104.1 33% 26.1  
Subtotal other activities 1626 162.6 61% 46.0 1964 196.4 62% 58.1  
Total activities 2665 266.5 100% 43.4 3143 314.3 100% 70.0  
Table 6 Counter work  












Sum total Mean Percentage of 










Brief medication browse  614 61.4 51% 17.8 601 60.1 57% 14.5  
First time use 130 13.0 11% 7.6 116 11.6 11% 4.5  
Second time use 21 2.1 2% 1.4 31 3.1 3% 2.8  
Instruction 6 0.6 1% 1.0 7 0.7 1% 1.1  
Medication surveillance 2 0.2 0% 0.4 8 0.8 1% 1.1  
Medication counseling 10 1.0 1% 1.1 11 1.1 1% 1.1  
Self care 68 6.8 6% 3.9 49 4.9 5% 3.3  
Information about disease or 
lifestyle 4 0.4 0% 1.0 4 0.4 0% 0.7  
Subtotal care-related activities 855 85.5 71% 25.8 827 82.7 79% 20.6  
Only social 2 0.2 0% 0.4 26 2.6 2% 3.1 ** 
Other 26 2.6 2% 2.2 40 4.0 4% 4.3  
No information 314 31.4 26% 12.9 159 15.9 15% 8.7 ** 
Subtotal other activities 342 34.2 29% 13.8 225 22.5 21% 13.3  
Total activities 1197 119.7 100% 25.9 1052 105.2 100% 25.8  
 
 
situation (based on tables 2 and 5). Based on the average year salary reported 
by the pharmacy (EUR 37,000 salary) this extra work was estimated on EUR 
13,024 per year.  
The merits of the robot comprised decreases of workload, waiting time, 
and congestion; and an increase of slack. Moreover, a decrease of filling and 
logistical work and increases of counter work and pharmaceutical care were 
observed. The calculated weighted decrease of workload was .3 FTE (based on 
table 2); by combining this result with the average year salary this merit was 
estimated to be EUR 11,100 per year. The decrease of waiting time was one 
minute 18 seconds per patient (.022 hours), and which is derived from table 3. 





1600 working hours per year per person, and the average year salary, as 
reported by the pharmacy, the merits of the decrease of waiting time were  
estimated on EUR 17,050 per year. The decrease of congestion was one hour 
27 minutes and 36 seconds per day (7.3 hours per week), and which is shown in 
table 4. Based on the number of weeks and working hours per year per person, 
and the average year salary, the merits of the decrease of congestion were 
estimated on EUR 8,778 per year. The increase of slack was 28 minutes per day 
(2.3 hours per week), and which is shown in table 4. Based on the number of 
weeks and working hours per year per person, and the average year salary, the 
merits of the increase of slack were estimated on EUR 2,766 per year. 






Table 7 Estimated costs and merits of the robot in the first year 
Items Costs 
in first year 
Merits 
in first year 
Initial purchase EUR 150,000  
Depreciation 
(EUR 150,000 purchase/10 years) EUR 15,000  
Maintenance EUR 9,000  
Extra work to overcome technical failure of robot  
(.04 robot work*8.8 FTE*EUR 37,000 salary) EUR 13,024  
Decrease of workload 
(.3 FTE*EUR 37,000 salary) 
 EUR 11,100 
Decrease of waiting time 
((.022 hours*644.5 patients*52 weeks)/1,600 hours)*EUR 37,000 
salary 
 EUR 17,050 
Decrease of congestion 
((7.3 hours*52 weeks)/1,600 hours)*EUR 37,000 salary 
 EUR 8,778 
Increase of slack 
((2.3 hours*52 weeks)/1,600 hours)*EUR 37,000 salary 
 EUR 2,766 
Decrease of filling and logistical work  
(.07 filling and logistical work*8.8 FTE*EUR 37,000 salary) 
 EUR 22,792 
Increase of counter work 
(.07 counter work*8.8 FTE*EUR 37,000 salary) 
 EUR 22,792 
Increase of pharmaceutical care  
(.08 care related work at the counter*2 FTE counter 
assistants*EUR 37,000 salary) 
 EUR 5,920 
Total EUR 187,024 EUR 91,198 
 
The decrease of filling and logistical work and the 
increase of counter work were both 7% of the 
total FTE in the new situation (tables 2 and 5). 
Based on the average year salary these merits 
were estimated on EUR 22,792 each, per year. 
The increase of pharmaceutical care is shown in 
table 6 and was a total increase of 8% of care-
related activities. By combining this increase with 
a mean capacity utilization of two FTE for 
counter work in the new situation and the average 
year salary as reported by the pharmacy, this 
merit was estimated on EUR 5,920 per year. 
Consequently, the total estimated costs were EUR 
187,024 and the merits were EUR 91,198 in the 
first year. 
 
Table 8 shows the estimated payback time of the 
robot, based on the estimations of table 7. Within 
this line of thought the break even point was 
passed after three years. At that time the merits 
were EUR 12,522 higher than the costs. 
 
Table 8 Estimated payback time of the robot 
 Costs Merits 
Year 1 EUR 187,024 EUR 91,198 
Year 2 EUR 224,048 EUR 182,396 




Be reminded that this study included eight main 
topics: basic costs of the robot, workload, waiting 
times, congestion and slack, general work, 
counter work, consultation-room work, and 
overall economics of the robot. All topics will be 
discussed briefly and converge in a general 
conclusion about the merits of the robot in this 
Dutch pharmacy.  
Firstly, the basic costs of the robot were 
determined on EUR 174,000 in the first year. The 
costs are high and support the idea that the robot 
is expensive and has substantial depreciation and 
maintenance costs.  
Secondly, the workload was higher in the 
pre test without robot than in the post test with 
robot. In the robot situation each staff member 
handled 15 prescriptions less a day. This may 
have affected at least parts of the results of the 
study. However, if all other things are kept equal, 
the total pharmacy working systems needs 6.8 
FTE in stead of 7.1 FTE to dispense the observed 
14,410 prescriptions of the pre test (table 2). The 
robot working system needs .3 FTE less for 
staffing in a situation with a robot; estimated on 
EUR 11,000.  






Thirdly, the waiting times have decreased 
with one minute and 18 seconds per dispensing 
process; estimated on EUR 17,050. On one hand, 
it has reduced the ‘nasty’ waiting times before 
counter contact. These are the times during which 
the patient is not yet being helped and that have 
the potential to lead to impatience, frustration and 
annoyance [12]. On the other hand, it has kept the 
good ‘waiting’ time after counter contact stable. 
These are the times during which the patient is 
helped and that have the potential to lead to a 
pharmacotherapeutic consultation. 
Fourthly, the other efficiency advantages 
at congestion and slack were also very important. 
The observed congestion was reduced with one 
hour, 27 minutes and 36 seconds and the observed 
slack was increased with 28 minutes; with half 
and similar frequencies respectively. Both 
benefits were estimated on EUR 11,544. As a 
consequence, each day 16% of the opening hours 
became normal in stead of stressful, creating more 
time to have a conversation. The stressful 
moments were also less frequent: 12 in stead of 
24 a day. It also meant that each day 5% of the 
opening hours became silent, creating time to do 
other work. These peaceful moments were 
comparable, but slightly more frequent: 21 in 
stead of 18 a day. 
 Fifthly, the time-interval studies of the 
general work showed a 7% increase of the counter 
work and the 4% decrease of the filling work in 
the presence of the patient. These results suggest 
that the observed efficiency advantages were 
actually used for the provision of care. Although 
robot introduction produces significant negative 
side effects of costs and technical failure, these 
positive effects at the general work are also of 
considerable importance. At first sight the time-
interval studies showed that the work has ‘just’ 
been re-shuffled: there was no appreciable 
difference in the proportion between the care-
related activities and the other activities. 
However, with a detailed analysis of the care-
related activities positive effects were observed at 
counter work, exactly at the place where a care-
oriented pharmacist would wish them to have: a 
7% increase at counter work; estimated on EUR 
22,792. Moreover, it also illuminated a 9% 
decrease at telephone, computer work, and home 
delivery work where at least parts of the work 
content will also have related to other work 
content, and therefore not completely being care-
related. Because the care and other activities were 
so intermingled, we did not calculate these 
benefits in financial terms. Within the other 
activities the main outcome of the re-shuffling 
was dimming effects on filling and logistical 
work: a 7% decrease; also estimated on EUR 
22,792. However, there was also a 4% increase at 
robot work to overcome technical problems; 
estimated on EUR 13,024. In the overall results of 
the time-interval studies, the 7% increase at 
counter work, the 7% decrease of filling and 
logistical work, and the 4% increase of robot 
work were found to be the most important effects 
of the robot introduction, mainly because of their 
statistical significance and their relation with the 
implemented logistical changes.  
 Sixthly, counter-tally studies showed a 
rise in care-related activities with 8%; this merit 
was estimated on EUR 5,920 per year. Moreover, 
it also illuminated an important increase at brief 
medication browse (6%) and social conversations 
(2%), and a very important decrease at counter 
contacts where no information was provided 
(11%), although only the latter two were 
statistically significant. In the overall results of 
the counter-tally studies therefore the 11% 
decrease in the counter contacts where no 
information was provided and the 2% increase of 
social conversations were the most important 
effects of the robot introduction, because of their 
statistical significance and their relation with the 
implemented logistical changes. However, only 
the 8% increase in care-related activities was 
calculated in financial terms because it is believed 
to represent the major shift in work at the counter. 
Seventhly, the consultation-room work 
was never performed during the study: the room 
was unused. This is remarkable because the 
separate room is generally accepted as a pre-
condition that allows the provision of 
pharmaceutical care in The Netherlands.  
Eighthly, the overall economics of the 
robot support the idea that the robot is expensive, 
has substantial maintenance cost, and makes the 
pharmacy working system more vulnerable, as it 
is liable to have troubles. The estimated expenses 
per year were EUR 187,024 in the first year and 
EUR 37,024 in the years after. However, the 
robot also has substantial benefits at the topics of 
workload, waiting time, congestion and slack, 
logistics, counter work, and pharmaceutical care. 
The estimated benefits per year were EUR 91,198 
in the first year and after. If we combine these 
results we can derive that the financial pay-back 
time of the robot was three years. 
The results suggest that the robot is 
expensive, but also that it improves efficiency of 
the pharmacy work, and by doing so, may 






actually support a transition in the work at the 
pharmacy from logistics to care. The advantages 
in terms of efficiency and pharmaceutical care are 
very promising. But what explains the efficiency 
advantages?  
Firstly, the changes in the nature of the 
filling work were strong at this pharmacy. In the 
situation without a robot the filling work was a 
separate working station on another location. The 
staff had to move their and back, creating time 
disadvantages. In the situation with the robot, the 
product outlet was only steps away from the 
counter eliminating most of these disadvantages, 
which could in turn be used for patient contact.  
Secondly, the human search process in 
the regular supply closet was eliminated at this 
pharmacy. The robot delivered the stock request 
in its outlet transforming the search into a stop-
and-go action. Consequently, the work could be 
done more easily, creating a shorter wait and 
more space for conversations at the counter, and 
being accountable for a main part in the observed 
positive effects at the care-related activities.  
 Proximity of stock in the counter 
area and replacement of human with nonhuman 
technology for specific logistic tasks may indeed 
be a good design principle for many pharmacies, 
and it may in fact also have general applicability. 
However, be reminded that these positive effects 
for pharmaceutical care remain vulnerable. They 
only hold under the condition ceteris paribus. If 
the pharmacist decides to keep the staffing stable, 
which was done at this pharmacy, the available 
workforce is reallocated to other work. But to 
what other work? Scientifically there is no 
guarantee that the time advantage really is a 
change for the better for pharmaceutical care. 
Robotization can also be used easily for a sole 
cost-reduction of staff expenses, for instance, at 
times of financial setback or staff shortage in the 
labor market. In this view the robot must also be 
regarded as a substantial financial investment in 
which the recovery of the cost plays an important 
role. Cheaper low educated staff may actually 
replace parts of the educated pharmacy staff, 
without any benefits for pharmaceutical care. 
Whichever way one looks at it, money and care 
remain communicating vessels. The strong 
interdependencies between economics and 
pharmaceutical care could drive pharmacists or 
other decision-makers into sole cost-reduction. To 
what extent the robot actually improves 
pharmaceutical care will always depend on the 
intentions and qualities of the individual 
pharmacist and on the business context. As such, 
robotization has the potential to advance 
pharmaceutical care in the pharmacy, but its 
actual contribution can only be determined when 




The study has shown that the introduction of a 
robot, when combined with increased staffing, has 
important drawbacks which should not be 
ignored, but it also has interesting merits.  
On one hand, the observed drawbacks of 
the robot remain the high initial costs, 
depreciation, maintenance costs, and new robot 
work to overcome problems of technical failure. 
Hence, the estimated pharmacy expenditures were 
EUR 187,024 in the first year.  
On the other hand, the observed merits of 
the robot consist of positive impact on waiting 
times, congestion, staffing, logistics, and care-
related activities. In terms of the general work the 
study revealed more counter work and less filling 
work. In terms of the counter work it was shown 
that in general more care-related activities were 
present at the pharmacy. Finally, less counter 
contacts without information were observed and 
more social conversations. The estimated merits 
were EUR 91,198 in the first year. In combining 
the costs and merits, the estimated payback time 
of the robot was three years. 
This all leads to the conclusion that an 
introduction of the robot may indeed have the 
often supposed positive effects on pharmaceutical 
care. Even though the costs are high and the 
technical problems are present, the robot seems to 
be financial beneficial after three years. So, if the 
robot is combined with an intention of the 
pharmacist to improve pharmaceutical care it can 
create space for pharmaceutical care. New studies 
should illuminate if these observations hold in a 
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